• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab?

作者信息

Bendtzen K, Steenholdt C

机构信息

Institute for Inflammation Research, Rigshospitalet, Copenhagen, Denmark.

Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.

出版信息

Aliment Pharmacol Ther. 2017 Mar;45(5):759-760. doi: 10.1111/apt.13921.

DOI:10.1111/apt.13921
PMID:28150453
Abstract
摘要

相似文献

1
Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab?信函：对于使用阿达木单抗治疗的患者，添加一种免疫调节剂真的能逆转抗体形成和反应丧失吗？
Aliment Pharmacol Ther. 2017 Mar;45(5):759-760. doi: 10.1111/apt.13921.
2
Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.药物和抗体的水平与英夫利昔单抗或阿达木单抗治疗应答失败后的干预效果相关。
Clin Gastroenterol Hepatol. 2015 Mar;13(3):522-530.e2. doi: 10.1016/j.cgh.2014.07.029. Epub 2014 Jul 25.
3
Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.
Aliment Pharmacol Ther. 2017 Jan;45(1):178-179. doi: 10.1111/apt.13842.
4
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD.抗 TNF 治疗停药后抗药物抗体滴度下降：对预测 IBD 再诱导治疗结局的影响。
Aliment Pharmacol Ther. 2012 Mar;35(6):714-22. doi: 10.1111/j.1365-2036.2012.04997.x. Epub 2012 Jan 30.
5
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study.英夫利昔单抗与阿达木单抗治疗克罗恩病的比较：澳大利亚和新西兰一项观察性队列研究中327例患者的结果
Aliment Pharmacol Ther. 2017 Feb;45(4):542-552. doi: 10.1111/apt.13880. Epub 2016 Dec 19.
6
Influence of combination therapy with immune modulators on anti-TNF trough levels and antibodies in patients with IBD.免疫调节剂联合治疗对炎症性肠病患者抗TNF谷浓度及抗体的影响。
Inflamm Bowel Dis. 2014 Dec;20(12):2292-8. doi: 10.1097/MIB.0000000000000208.
7
Plasma trough levels of adalimumab and infliximab in terms of clinical efficacy during the treatment of psoriasis.治疗银屑病过程中阿达木单抗和英夫利昔单抗的血药谷浓度与临床疗效的关系。
J Dermatol. 2013 Jan;40(1):39-42. doi: 10.1111/j.1346-8138.2012.01679.x. Epub 2012 Oct 5.
8
Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis.抗阿达木单抗和英夫利昔单抗中和抗体对银屑病治疗的影响。
Br J Dermatol. 2014 Apr;170(4):922-9. doi: 10.1111/bjd.12791.
9
Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? Authors' reply.信函：在接受阿达木单抗治疗的患者中添加免疫调节剂真的能逆转抗体形成和反应丧失吗？作者回复。
Aliment Pharmacol Ther. 2017 Mar;45(5):760-762. doi: 10.1111/apt.13932.
10
Letter: double-dose intensification - a quick way to reverse antibody formation and loss of response in patients treated with adalimumab.
Aliment Pharmacol Ther. 2019 Mar;49(6):821-822. doi: 10.1111/apt.15124.